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Background: Mutations or deletions in DJ-1/PARK7 gene are causative for recessive forms of early onset Parkinson’s
disease (PD). Wild-type DJ-1 has cytoprotective roles against cell death through multiple pathways. The most
commonly studied mutant DJ-1(L166P) shifts its subcellular distribution to mitochondria and renders cells more
susceptible to cell death under stress stimuli. We previously reported that wild-type DJ-1 binds to Bcl-XL and
stabilizes it against ultraviolet B (UVB) irradiation-induced rapid degradation. However, the mechanisms by which
mitochondrial DJ-1(L166P) promotes cell death under death stimuli are largely unknown.
Results: We show that DJ-1(L166P) is more prone to localize in mitochondria and it binds to Bcl-XL more strongly
than wild-type DJ-1. In addition, UVB irradiation significantly promotes DJ-1(L166P) translocation to mitochondria
and binding to Bcl-XL. DJ-1(L166P) but not wild-type DJ-1 dissociates Bax from Bcl-XL, thereby leading to Bax
enrichment at outer mitochondrial membrane and promoting mitochondrial apoptosis pathway in response to UVB
irradiation.
Conclusion: Our findings suggest that wild-type DJ-1 protects cells and DJ-1(L166P) impairs cells by differentially
regulating mitochondrial Bax/Bcl-XL functions.
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Parkinson’s disease (PD), a common neurodegenerative
movement disorder, is associated with progressive loss
of dopaminergic neurons in the substantia nigra pars
compacta (SNpc) [1]. DJ-1, a product of DJ-1/PARK7
gene, was originally identified as an oncogene protein
that protects cells against stress through multiple path-
ways including gene transcription regulation, protein
stabilization, signal transduction and reactive oxygen
species (ROS) elimination [2,3]. Recently, DJ-1 has
attracted more attention due to its involvement in fa-
milial early onset PD as its deletion mutants or point
mutations including L166P, A104T, M26I, D149A,
E64D and L10P cause PD [1,4,5]. DJ-1(L166P) was the
most commonly studied and traditionally considered as
“loss of function by degradation” because of its instabil-
ity and misfolded structure compared with wild-type
DJ-1 [6-8]. In addition, DJ-1(L166P) exists as a* Correspondence: wanggh@suda.edu.cn
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reproduction in any medium, provided the ormonomer, whereas wild-type DJ-1 exists as homodi-
mers in cells [6,9]. However, many lines of recent evi-
dence indicated that DJ-1(L166P) renders cells more
susceptible to cell death under death stimuli [10-14].
Mitochondrial dysfunction is the key and common
causative factor for pathogenesis of PD [1,15-19]. In PD
patients and experimental PD models, dopaminergic
neurodegeneration is caused at least partly by activation
of mitochondria-dependent programmed cell death 2
(PCD) pathways [20,21]. For instance, positive Bax, cas-
pase-3, caspase-9 have been observed in SNpc dopa-
minergic neurons in PD models [22-24]. In addition,
PD-associated proteins such as PINK1, parkin and DJ-1
directly affect mitochondrial functions [25-29]. DJ-1 de-
ficiency leads to impairments of mitochondrial con-
nectivity, fusion rates, membrane potential (ΔΨm),
respiratory capacity and ROS scavenging [25,30-33].
Interestingly, wild-type DJ-1 partially localized in mito-
chondria and DJ-1 mutants including L166P are more
prone to mitochondrial localization [5,8,12,34,35].
Moreover, both wild-type DJ-1 and DJ-1(L166P) are
enriched in the mitochondrial fraction under death. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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impairs cells or neurons by “gain of function by trans-
location to mitochondria”. In addition, the physiological
roles of their translocation to mitochondria under
oxidative stress are still unclear because wild-type DJ-
1 translocation to mitochondria under oxidative stress
is required for its oxidation of Cys106 [34], but DJ-1
(L166P) can not be oxidized [13], suggesting that
these two proteins may differentially function in
mitochondria.
Recently, we reported that wild-type DJ-1 translocates
to mitochondria and binds to Bcl-XL in response to
UVB irradiation and inhibits Bcl-XL rapid degradation
and mitochondrial apoptosis pathway induced by UVB
irradiation [37]. However, the roles of DJ-1(L166P) in
mitochondria during oxidative stress are largely un-
known. In this study, we further showed that DJ-1
(L166P) binds more tightly to Bcl-XL than wild-type DJ-
1. Under UVB irradiation, DJ-1(L166P) translocates to
mitochondria to dissociate Bax from Bcl-XL by its inter-
action with Bcl-XL, resulting in an increased susceptibil-
ity of cells to UVB irradiation-induce cell death. Our
results suggest that DJ-1 and DJ-1(L166P) differentially
regulate Bcl-XL functions in control of the mitochondrial
apoptotic pathway.
Results
Subcellular distribution of wild-type DJ-1 and DJ-1(L166P)
Considering that DJ-1 and its pathogenic mutant DJ-1
(L166P) have potential functions in mitochondria,
we first examined the subcellular localization of DJ-1
and DJ-1(L166P) in HEK293 cells. DJ-1-Myc was dis-
tributed diffusely in both the cytoplasm and nucleus,
with a small portion co-localized with MitoTracker
(green) (Figure 1A and 1B). However, DJ-1(L166P)-Myc
was dominantly presented in the mitochondria with
much less nuclear and cytosolic distribution (Figure 1A).
Quantitative analysis showed that approximately 81.3%
of cells transfected with DJ-1(L166P) displayed a mito-
chondrial localization, and approximately 18.7% of them
displayed a cytosolic localization (Figure 1B). Consistent
with the immunocytochemical results, subcellular frac-
tionation assays also showed that both of distribution
ratio and protein level of DJ-1(L166P) in the mitochon-
drial fraction were much higher than those of wild-type
DJ-1, although the total protein level of DJ-1(L166P) was
much less than that of wild-type DJ-1 (Figure 1C and
1D). The lower level of Flag-DJ-1(L166P) protein com-
pared to Flag-DJ-1 should be caused by that L166P mu-
tant is unstable and degraded rapidly through the
ubiquitin proteasome system (UPS), when equal
amounts of plasmids are used for transfection [6,7,38].
The mitochondrial localization of wild-type DJ-1 and its
mutants increases under oxidative stresses such asparaquat treatment,H2O2 and UV irradiation [34,36].
Consistent with those findings, we observed that UVB
irradiation increased the mitochondrial localization of
both endogenous DJ-1 and Flag-DJ-1(L166P), but did
not change total protein levels of them (Figure 1E and
1F). These results indicated that DJ-1(L166P) is prone to
mitochondrial localization and the mitochondrial distri-
bution of wild-type DJ-1 and DJ-1(L166P) are increased
in response to UVB irradiation.
Interactions between Bcl-XL and DJ-1(L166P)
In our previous study, we showed that wild-type DJ-1
translocates to mitochondria to bind to Bcl-XL in re-
sponse to UVB irradiation [37]. Considering that DJ-1
(L166P) is mainly distributed in mitochondria, and
translocates more to mitochondria under oxidative
stress, we wonder whether DJ-1(L166P) binds to Bcl-XL.
Although the interactions of wild-type DJ-1 and DJ-1
(L166P) with Bcl-XL were not significant different in
GST pulldown assays in vitro (Figure 2A), more DJ-1
(L166P) than wild-type DJ-1 bound to Bcl-XL in cells
(Figure 2B). Neither wild-type DJ-1 nor DJ-1(L166P)
bound to Bcl2 and Bax, another two typical Bcl-2 family
proteins (data not shown). These data suggested that
wild-type DJ-1 and DJ-1(L166P) specifically bind to Bcl-
XL. The monoclonal anti-Bcl-XL antibody used in
Figure 2B is suitable for immunoprecipitation assays as
Flag-Bcl-XL could be immunoprecipitated by anti-Bcl-XL
antibody but not by control mouse serum IgG (Add-
itional file 1: Figure S1). Consistent with data from
immunoprecipitation analyses, immunocytochemical
studies showed that DJ-1(L166P)-Myc, but not DJ-1-
Myc, was well co-localized with EGFP-Bcl-XL in
HEK293 cells (Figure 2C). We also examined the inter-
actions between Bcl-XL and another pathogenic DJ-1
mutant, DJ-1(M26I). Similar to DJ-1(L166P), DJ-1(M26I)
interacted with Bcl-XL and co-localized with Bcl-XL
(Additional file 1: Figure: S2). As DJ-1(L166P) increased
in mitochondria under UVB irradiation (Figure 1E and
1F), we next performed immunoprecipitation assays to
test if the interaction of Bcl-XL with DJ-1(L166P) is
affected by UVB irradiation. Interestingly, the binding af-
finity of Flag-DJ-1(L166P) for EGFP-Bcl-XL significantly
increased after UVB irradiation (Figure 2D). In addition,
UVB irradiation led to larger punctate DJ-1(L166P)-RFP
spots co-localizing with EGFP- Bcl-XL (Figure 2E).
Moreover, the mitochondria exhibited more severe ab-
normalities in cells harboring DJ-1(L166P) under UVB
irradiation (Figure 2E).
Requirement of the C-terminal of Bcl-XL for DJ-1(L166P)
binding
We previously found that wild-type DJ-1 mainly binds
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Figure 1 Subcellular distribution of wild-type DJ-1 and DJ-1(L166P) in mitochondria. (A) HEK293 cells transiently transfected with Myc
(control), DJ-1-Myc or DJ-1(L166P)-Myc along with Mito-EGFP were subjected to immunocytochemical staining with anti-Myc antibodies (red) and
then labeled with the nuclear marker DAPI (blue). Bar, 10 μm. (B) The percentage of cells transfected with DJ-1-Myc or DJ-1(L166P)-Myc
presenting mitochondrial or cytosolic staining in (A) was quantified (mean ± S.E.M., n = 3; by one-way ANOVA). (C) H1299 cells transiently
transfected with Flag, Flag-DJ-1 or Flag-DJ-1(L166P) were subjected to subcellular fractionation. The total cell lysate and the cytosolic and
mitochondrial fractions were subjected to immunoblot analysis. (D) The distribution ratio of Flag-DJ-1 or Flag-DJ-1(L166P) in cytosolic or
mitochondrial fractions to their total level in (C) were analyzed using densitometric analysis (mean ± S.E.M., n = 3; by one-way ANOVA). (E) H1299
cells transiently transfected with Flag-DJ-1(L166P) were treated with or without 80 mJ/cm2 UVB irradiation, and the cells were then subjected to
the subcellular fractionation assay. The total cell lysate, cytosolic and mitochondrial fractions were subjected to immunoblot analysis. (F) The
relative level of Flag-DJ-1(L166P) in (E) were analyzed using densitometric analysis (mean ± S.E.M., n = 3; by one-way ANOVA).
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(L166P) binds to the same amino acids of Bcl-XL. Sur-
prisingly, DJ-1(L166P) bound to the C-terminal frag-
ment of Bcl-XL at amino acids 196–233 (Figure 3A).
We further examined the regions of Bcl-XL binding to
DJ-1(L166P) in H1299 cells. Similar to the results fromGST pulldown assays, EGFP-Bcl-XL
196-233 but not
EGFP-Bcl-XL
1-195 was found to interact with Flag-DJ-1
(L166P) (Figure 3B). These results suggest that DJ-1
(L166P) and wild-type DJ-1 bind to different domains
of Bcl-XL, indicating that they may regulate Bcl-XL
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Figure 2 Interactions between Bcl-XL and DJ-1(L166P). (A) The supernatant of E. coli crude extract containing 50 μg of recombinant Bcl-XL
was incubated with 20 μg of GST, GST-DJ-1 or GST-DJ-1(L166P) coupled to glutathione-agarose beads. The bound proteins were detected by
immunoblot analysis. (B) H1299 cells transiently transfected with Flag-DJ-1 or Flag-DJ-1(L166P) were subjected to immunoprecipitation with
normal mouse serum or anti-Bcl-XL antibody. (C) HEK293 cells transfected with Myc, DJ-1-Myc or DJ-1(L166P)-Myc along with EGFP-Bcl-XL were
subjected to immunocytochemical staining with anti-Myc antibodies (red) and then labeled with DAPI (blue). Bar, 10 μm. (D) H1299 cells
transfected with Flag-DJ-1(L166P) along with EGFP or EGFP-Bcl-XL were treated with or without 80 mJ/cm
2 UVB irradiation. Supernatants of the
cell lysates were then subjected to immunoprecipitation with anti-GFP antibodies. (E) HEK293 cells transiently transfected with RFP or DJ-1
(L166P)-RFP along with EGFP-Bcl-XL were treated with or without 80 mJ/cm
2 UVB irradiation, and then the cells were observed with an inverted
fluorescence microscope (Olympus, IX71). Bar, 10 μm.
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we showed that wild-type DJ-1 stabilizes Bcl-XL by its
inhibiting Bcl-XL under UVB irradiation. We therefore
examined if DJ-1(L166P) also stabilize Bcl-XL. Under
UVB irradiation, knockdown of DJ-1 decreased Bcl-XL
protein levels and re-overexpression of Flag-DJ-1(s), a
synonymous mutant that is resistant to si-DJ-1,
restored Bcl-XL protein levels, however, Flag-DJ-1
(L166P)(s) did not (Figure 3C and 3D). Meanwhile, theubiquitination of Bcl-XL was inhibited by DJ-1 but not
DJ-1(L166P) (Figure 3E).
Dissociation of Bax from Bcl-XL by DJ-1(L166P)
Bcl-2 family proteins mediate apoptosis in a manner
dependent on their homo- or hetero-dimerization [41].
Bcl-XL interacts with Bax to block its oligomerization
in the mitochondrial membrane, thereby protecting
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Figure 3 Requirement of the C-terminus of Bcl-XL for DJ-1(L166P) binding. (A) The supernatant of E. coli crude extract containing
recombinant His-DJ-1 or His-DJ-1(L166P) was incubated with GST, GST-Bcl-XL, GST-Bcl-XL(1–85), GST-Bcl-XL(86–195) or GST-Bcl-XL(196–233)
coupled to glutathione-agarose beads. The bound proteins were subjected to immunoblot analysis. (B) The supernatants of H1299 cells
transfected with EGFP, EGFP-Bcl-XL, EGFP-Bcl-XL(1–195) or EGFP-Bcl-XL(196–233) along with Flag-DJ-1(L166P) were subjected to
immunoprecipitation with anti-GFP antibodies. (C) H1299 cells transfected with si-NC or si-DJ-1 along with Flag, Flag-DJ-1(s) or Flag-DJ-1(L166P)(s)
were treated with or without 80 mJ/cm2 UVB irradiation. Total cell lysates were subjected to immunoblot analysis. (D) The relative ratios of Bcl-XL
to α-Tubulin in (C) were analyzed using densitometry (mean ± S.E.M., n = 3; **, p <0.01; ns, no statistical significance by one-way ANOVA). (E)
H1299 cells transfected with EGFP or EGFP-Bcl-XL along with Flag, Flag-DJ-1 or Flag-DJ-1(L166P) were treated with 80 mJ/cm
2 UVB and then with
5 μM Lactacystin for 16 hours. The supernatants of the cell lysates were subjected to immunoprecipitation with anti-GFP antibodies.
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BH1-2 domains and the C-terminus of Bcl-XL are
required for Bcl-XL/Bax heterodimer formation [43,44].
To investigate if DJ-1(L166P) affects the interactions
between Bcl-XL and Bax or Bcl-2, we performed com-
petitive binding assays. With less amount of His-DJ-1
(L166P), more Bax bound to Bcl-XL (Figure 4A).
However, the binding ability of Bcl-2 to Bcl-XL wasnot affected by His-DJ-1(L166P) (Figure 4B). To fur-
ther identify if DJ-1(L166P) influences the interactions
between Bcl-XL and Bax in mammalian cells, we
transfected various amounts of Flag-DJ-1(L166P) into
H1299 cells stably expressing EGFP-Bcl-XL or EGFP-
Bcl-XL
1-195 and performed immunoprecipitation assays.
Under UVB irradiation, the amount of endogenous






































































































































Figure 4 Dissociation of Bax from Bcl-XL by DJ-1(L166P). (A-B) Supernatant containing 50 μg of recombinant His-Bax (A) or Bcl2 (B) was
incubated with 20 μg of GST or GST-Bcl-XL coupled to glutathione-agarose beads. After being washed to remove unbound proteins, the
glutathione-agarose beads were incubated with various amounts of His-DJ-1(L166P) supernatant. The bound proteins were subjected to
immunoblot analysis. (C) H1299 cells stably expressing EGFP-Bcl-XL or EGFP-Bcl-XL(1–195) were transiently transfected with various amounts
of Flag-DJ-1(L166P) and treated with 80 mJ/cm2 UVB irradiation. The supernatants of cell lysates were subjected to immunoprecipitation
with anti-GFP antibodies. (D) The relative levels of Bax bound to EGFP-Bcl-XL in (D) were analyzed using densitometry (mean ± S.E.M., n = 3;
*, p <0.05; **, p <0.01; ***, p <0.001; by one-way ANOVA).
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and 4D). However, EGFP-Bcl-XL
1-195, which does not
interact with Bax [44], was unable to interact with
DJ-1(L166P) (Figure 4C).DJ-1(L166P) promotes cell death by interfering with
Bcl-XL/Bax heterodimerization
The mitochondrial localization of Bax is important for
its ability to induce cell death [41]. Because DJ-1 and
DJ-1(L166P) re-distribute to mitochondria upon UVB ir-
radiation but differentially influence Bcl-XL, we per-
formed cytosolic and mitochondrial fractionation assays
and MTT assays to examine the effects of DJ-1 and DJ-1
(L166P) on mitochondrial Bax translocation and cell
viability. We performed experiments in H1299 cells, a
p53 null cell line to exclude the possibility that DJ-1
inhibits Bax transcription by binding to p53 [45-47].
Because endogenous DJ-1 expression is abundant [48],
we constructed a H1299 cell line stably transfected withsh-DJ-1 to silence endogenous DJ-1 to examine the
effects of exogenous wild-type DJ-1 and DJ-1(L166P).
The knockdown efficiency of sh-DJ-1 is shown in
Figure 5A and 5B. In the absence of UVB irradiation,
neither Flag-DJ-1(s) nor Flag-DJ-1(L166P)(s) had signifi-
cant effects on the translocation of Bax from the cytosol
to the mitochondria in sh-DJ-1 cells (Figure 5C and 5D).
However, under UVB irradiation, less Bax was presented
in the mitochondrial fraction in cells transfected with
Flag-DJ-1(s), but more Bax was present in the mitochon-
drial fraction in cells transfected with Flag-DJ-1(L166P)
(s) (Figure 5C and 5D). Overexpression of Flag-DJ-1(s)
but not Flag-DJ-1(L166P)(s) significantly increased mito-
chondrial Bcl-XL in response to UVB irradiation
(Figure 5C and 5E). In addition, in the absence of death
stimulus, overexpression of Flag-DJ-1(s) or Flag-DJ-1
(L166P)(s) had no significant effects on Bcl-XL levels,
caspase-3 and PARP cleavage (Figure 5F) or cell viability
(Figure 5G). However, with UVB irradiation, Flag-DJ-1









































































































































































































































Figure 5 Promotion of cell death by DJ-1(L166P)-influenced Bcl-XL/Bax heterodimerization. (A) Cell lysates of H1299 cells stably expressing
sh-NC or sh-DJ-1 were subjected to immunoblot analysis. (B) The relative ratios of DJ-1 to α-Tubulin in (A) were analyzed using densitometry
(mean ± S.E.M., n = 3; ***, p <0.001; by one-way ANOVA). (C) H1299 cells stably expressing sh-DJ-1 were transfected with Flag, Flag-DJ-1(s) or
Flag-DJ-1(L166P)(s) and treated with or without 80 mJ/cm2 UVB irradiation. The cells were then subjected to subcellular fractionation. (D) The
relative level of Bax in (C) were analyzed using densitometry (mean ± S.E.M., n = 3; *, p <0.05; **, p <0.01; by one-way ANOVA). (E) The relative
level of Bcl-XL in mitochondria in (C) were analyzed using densitometry (mean ± S.E.M., n = 3; *, p <0.05; by one-way ANOVA). (F-G) H1299 cells
stably expressing sh-DJ-1 transfected with si-NC or si-Bcl-XL along with Flag, Flag-DJ-1(s) or Flag-DJ-1(L166P)(s) were treated with or without
80 mJ/cm2 UVB irradiation. Cell lysates were then subjected to immunoblot analysis (F) or the cells were analyzed with the MTT assay (G)
(mean ± S.E.M., n = 3; *, p <0.05; ns, no statistical significance by one-way ANOVA).
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(Figure 5F) and increased cell viability (Figure 5G). In
contrast to Flag-DJ-1(s), Flag-DJ-1(L166P)(s) greatly
increased the cleavage of both caspase-3 and PARP
(Figure 5F) and decreased cell viability (Figure 5G).
Moreover, the effects of DJ-1 and DJ-1(L166P) on cell
death under UVB irradiation were abrogated by Bcl-XL
knockdown (Figure 5F and 5G). These results suggest
that wild-type DJ-1 protects cells against UVBirradiation by inhibiting Bcl-XL degradation, but DJ-1
(L166P) promotes cell death by dissociating Bcl-XL/Bax
heterodimerization.
Discussion
Many studies have shown that wild-type DJ-1 and DJ-1
(L166P) are partially localized in mitochondria
[5,8,12,34,35], and that their mitochondrial distribution
is enhanced under death stimuli [34,36]. Several lines of
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protective roles by maintaining mitochondrial integrity,
fusion rates, membrane potential, respiratory capacity
and ROS elimination [25,30-33].
In our previous study, we identified that wild-type DJ-
1 is a novel partner of Bcl-XL in mitochondria, to
stabilize Bcl-XL [37]. Here, we found that DJ-1(L166P)
binds to Bcl-XL as well. However, DJ-1(L166P) does not
stabilize Bcl-XL but dissociates Bax from Bcl-XL. The
binding ability of DJ-1(L166P) to Bcl-XL is stronger than
that of wild-type DJ-1 (Figure 2B). In contrast to DJ-1
that interacts with Bcl-XL dependent on its oxidation
[37], DJ-1(L166P) interacts with Bcl-XL independent on
its oxidation as DJ-1(L166P) is a loss of oxidized form
[13]. In addition, DJ-1(L166P) binds to the C-terminus
of Bcl-XL (Figure 3A and 3B) which is required for Bcl-
XL/Bax heterodimer formation [44], but wild-type DJ-1
mainly binds to middle regions (Figure 3A) containing
BH1, BH2 and BH3 domains which are essential for Bcl-
XL stability [49,50]. Wild-type DJ-1 and DJ-1(L166P)
that bind to different domains of Bcl-XL may be due to
the fact that L166P mutant interrupts the normal folding
and exposes new domains or amino acid sites [38,51,52].
Taken together, our study suggests that the different
roles of DJ-1 and DJ-1(L166P) in mitochondria may re-
sult from the different oxidative status of these two pro-
teins and from their functioning differentially in
mitochondria.
L166P mutant prevents normal folding of wild-type
DJ-1 and itself is instable with a rapid degradation via
UPS [6,7,51,52]. However, DJ-1(L166P) appears not only
to be “loss of function” of wild-type DJ-1. It also forms
larger complexes with other proteins but not wild-type
DJ-1 [8]. Although DJ-1(L166P) loses the ability to bind
to proteins that wild-type DJ-1 does, such as Daxx [53],
DJ-1(L166P) existing as a monomer in cells may allow it
to gain an ability to bind to proteins that wild-type DJ-1
does not. For instance, DJ-1(L166P) and DJ-1(M26I)
bind more TTRAP than wild-type DJ-1 does, and they
block the protective activity of TTRAP, leading to cell
death [10]. Wild-type DJ-1 represses UV-induced JNK
activation to protects cells, but DJ-1(L166P) significantly
activates JNK pathway to promote cell death in response
to UV irradiation [11]. As much more DJ-1(L166P) is
translocated to mitochondria than wild-type DJ-1 under
UVB stimulation, and DJ-1(L166P), but not wild-type
DJ-1, dissociates Bax from mitochondrial Bcl-XL, it is
therefore possible that DJ-1(L166P) may gain functions
by translocation to mitochondria to affect mitochondrial
pathway. We also found that another PD-associated mu-
tant DJ-1(M26I) mainly distributes in mitochondria and
binds to Bcl-XL, similar to DJ-1(166P) (Additional file 1:
Figure S2). These results suggest that the mitochondrial
Bcl-XL/Bax pathway influenced by mutant DJ-1 might bea common mechanism involved in mutant DJ-1-
associated PD pathogenesis.
Mitochondrial dysfunction is a key feature involved
in both sporadic and genetic forms of PD [1,15-19].
Although familial PD is rare, to understand the
mechanisms and functions of familial PD-associated
proteins in mitochondria may shed light on the
pathogenesis of PD. Our findings suggest that wild-
type DJ-1 and DJ-1(L166P) differentially mediate Bcl-
XL functions providing us to further understand the
pathogenesis of PD.
Conclusion
We found that a small portion of wild-type DJ-1 and
most of DJ-1(L166P) is presented in mitochondria and
wild-type DJ-1 and DJ-1(L166P) increased in mitochon-
dria in response to UVB irradiation. DJ-1(L166P) binds
to mitochondrial Bcl-XL more tightly than wild-type DJ-
1 and UVB irradiation further promotes their binding af-
finity. Unlike wild-type DJ-1, DJ-1(L166P) fails to
stabilize Bcl-XL, but it dissociates Bax from Bcl-XL that
leading Bax enrichment in outer mitochondrial mem-
brane and subsequently triggers cell death in response to
UV irradiation. Our findings suggest that wild-type DJ-1
protects cells and DJ-1(L166P) impairs cells by differen-
tially regulating Bcl-XL functions. Our study provides a
novel insight into the underlying mechanisms of PD
pathogenesis.
Materials and methods
Cell culture and plasmid transfection
Human HEK293 cells, a human kidney cell line, and
H1299 cells, a human lung cancer cell line, were main-
tained in DMEM (Dulbecco’s modified Eagle’s medium)
supplemented with 10% fetal bovine serum (Hyclone,
USA). Plasmid transfections were performed using Lipo-
fectamine2000 reagent (Invitrogen, USA).
UVB irradiation treatment
HEK293 or H1299 cells were irradiated with UVB using
a UV crosslinker. Briefly, the cultured cells covered with
a thin layer of phosphate buffer solution (PBS, pH 7.4),
were exposed to UVB irradiation (312 nm) with 80 mJ/
cm2 with a UV crosslinker (SCIENTZ03-II, Ningbo,
China). After UVB irradiation, the cells were cultured
for 16 hours and subsequently subjected to additional
experiments.
siRNA or shRNA knockdown
si-DJ-1328 was described previously [47]. siRNA against
human Bcl-XL mRNA was purchased from GenePharma
(GenePharma, Shanghai, China) with the following
sequences: sense: 50-GAGAUGCAGGUAUUGGUGATT-
30, anti-sense: 50-UCACCAAUACCUGCAUCUCTT-30.
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mine reagent (Invitrogen, USA). Briefly, cultured cells
were washed with Opti-MEM medium (Invitrogen) and
then transfected with siRNA using Oligofectamine reagent
in Opti-MEM medium without serum. Six hours after
transfection, the culture medium was replaced with fresh
complete medium. The cells were subjected to further
experiments 72 hours after transfection. pGPU6/GFP/
Neo-sh-DJ-1 encoding a short hairpin RNA (shRNA)
against nucleotide 328 to 346 of human DJ-1 mRNA (sh-
DJ-1) or a negative control short hairpin (sh-NC) was con-
structed by GenePharma (GenePharma, Shanghai, China).
H1299 cells stably expressing sh-NC or sh-DJ-1 were
obtained by selection with 200 μg/ml Geneticin (Invitro-
gen, USA) after transfection.Plasmid constructs
Full-length DJ-1 in p3 × Flag-myc-cmv-24, pET-15b,
pDsRed-N1, pmyc-cmv-24 and pGEX-5x-1, and pET-21a-
Bcl2, pET-21a-Bax, pET-21a-Bcl-XL, pEGFP-C2-Bcl-XL,
p3 × Flag-myc-cmv-24-Bcl-XL, pGEX-5x-1-Bcl-XL(1–85),
pGEX-5x-1-Bcl-XL(86–195) and pGEX-5x-1-Bcl-XL(196–
233) were described previously [37]. pEGFP-C2-Bcl-XL
(1–195) and pEGFP-C2-Bcl-XL(196–233) were created by
subcloning PCR products into pEGFP-C2 at its EcoRI/SalI





233aa. DJ-1(L166P) and DJ-1(M26I) mutants were
obtained by site-directed mutagenesis using wild-type




TAATCCCAGC-30, for DJ-1(M26I); respectively. Two
synonymous mutants, p3 × Flag-myc-cmv-24-DJ-1(s) and
p3× Flag-myc-cmv-24-DJ-1(L166P)(s), that are resistant
to si-DJ-1328 and sh-DJ-1 were described previously [54].Immunocytochemistry
HEK293 cells were washed with PBS and fixed with 4%
paraformaldehyde. After being blocked with 4% fetal bo-
vine serum containing 0.25% Triton X-100 in PBS, the
cells incubated with rabbit anti-myc polyclonal anti-
bodies (Santa Cruz Biotechnology, USA) followed by an
incubation with rhodamine-conjugated donkey anti-
rabbit IgG (Santa Cruz biotech, Inc). After staining with
DAPI (40,6-diamidino-2-phenylindole), the labeled cells
were observed using an inverted fluorescent microscope
(Olympus, IX71).GST pulldown assay
Equal amounts of GST or GST-fused proteins (20 μg)
expressed by Escherichia coli strain JM109 were incu-
bated with 20 μl of glutathione agarose beads (Pharma-
cia, USA) for 30 min at 4°C. After washing three times
with ice-cold PBS, the beads were incubated with 50 μg
of His-fused protein expressed by Escherichia coli strain
BL21 for 2 hours at 4°C. After incubation, the beads
were washed five times with ice-cold HNTG buffer
(20 mM Hepes-KOH, pH 7.5, 100 mM NaCl, 0.1% Tri-
ton X-100 and 10% glycerol). Bound proteins were
eluted from the beads and subjected to immunoblot
analysis with specific antibodies. The input represents
10% of the protein that was incubated with GST or a
GST-fused protein. The inputs of purified GST and
GST fusion proteins are stained with Coomassie Bril-
liant Blue (CBB) or anti-GST antibody.Immunoprecipitation assay
The cells were lysed in 1 ml cell lysis buffer (50 mM
Tris–HCl pH 7.5 buffer containing 150 mM NaCl, 1%
NP40 and 0.5% deoxycholate) supplemented with the
protease inhibitor cocktail (Roche, USA) for 30 min at
4°C. After centrifugation at 12,000 g for 15 min at 4°C,
the supernatants were incubated with appropriate anti-
bodies coupled to protein G Sepharose (Roche, USA).
The immunoprecipitants were then washed five times
with cell lysis buffer. Bound proteins and cell lysates
were subjected to immunoblot analysis. The input
represents 10% of the supernatant used in the co-
immunoprecipitation experiment.Immunoblot analysis and antibodies
Proteins were separated by 12% or 15% SDS-PAGE and
subjected to immunoblot analysis with specific anti-
bodies. The following primary antibodies were used:
Monoclonal anti-Bcl2, anti-Bcl-XL, anti-GFP, anti-GST,
anti-Tom20, anti-Ub and polyclonal anti-Myc, anti-Bax,
anti-Max antibodies were purchased from Santa Cruz
Biotechnology. Polyclonal anti-Bcl-XL, anti-cleaved cas-
pase-3 and anti-PARP antibodies were from Cell Signal-
ing. Polyclonal anti-DJ-1 antibodies were purchased
from Chemicon. Monoclonal anti-Flag-HRP and anti-α-
Tubulin antibodies were purchased from Sigma. Mono-
clonal anti-GAPDH antibody was from Millipore. The
secondary antibodies, sheep anti-mouse IgG-HRP and
anti-rabbit IgG-HRP were purchased from Amersham
Pharmacia Biotech. The proteins were visualized using
an ECL detection kit (Amersham Pharmacia Biotech).
Immunoblot densitometric analysis of data from three
independent experiments was performed using Photo-
shop 7.0 (Adobe, USA).
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The cytosolic and mitochondrial fractions were isolated
using Mitochondria Isolation Kit for Cultured Cells
(Beyotime, China). The total cell lysates and isolated
fractions were subjected to immunoblot analysis with
specific antibodies. Tom20, α-Tubulin and Max served
as the mitochondrial, cytosolic and nuclear maker,
respectively.
Cell viability assay
The cell viability was measured by MTT (methylthiazo-
letetrazolium) assay. Briefly, the cells were washed with
DMEM without phenol red (Gibco, USA) and incubated
with 0.5 mg/ml MTT (Sigma) for three hours. The
medium was removed and the formazan crystals were
dissolved in DMSO (dimethyl sulfoxide). Cell viability
was measured by spectrometry at OD570. The data were
normalized to a control and the ratios are presented as
means ± S.E.M from three independent experiments.
Statistical analysis
The data were analyzed by one-way analysis of variance
(ANOVA) using origin 6.0 software (Originlab, USA).
Values are shown as mean ± S.E.M.
Additional file
Additional file 1: Figure S1. Anti-Bcl-XL antibody was suitable for
immunoprecipitation. The supernatants of HEK293 cells that were
transiently transfected with Flag-Bcl-XL were subjected to
immunoprecipitation analysis using normal mouse serum or anti-Bcl-XL
antibody. Figure S2. DJ-1(M26I) also interacted and co-localized with Bcl-
XL in cells. (A) HEK293 cells were co-transfected with EGFP or
EGFP-Bcl-XL along with Flag-DJ-1, Flag-DJ-1(L166P) or Flag-DJ-1(M26I)
as indicated, the supernatants of cell lysates were subjected to
immunoprecipitation analysis using anti-GFP antibodies. (B) HEK293 cells
transiently transfected with DJ-1(M26I)-Myc with EGFP-Bcl-XL were
subjected to immunocytochemical staining with anti-Myc antibodies
(red), Bar, 10 μm.
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